In a recent publication, we unveiled a comprehensive list of the 10 Best Long Term Stocks to Buy According to Billionaires. Among these notable companies, Eli Lilly and Company (NYSE:LLY) has garnered attention, prompting a closer examination of its standing compared to other leading long-term investments.

Dividend-paying stocks have long been regarded as a crucial component of investment portfolios, serving as a reliable source of income while providing a safety net during market fluctuations. These stocks inherently offer investors a cushion, but they have occasionally found themselves at a disadvantage, particularly when compared to the more glamorous tech stocks that have dominated headlines in recent years. For instance, during a period when tech stocks soared, many dividend stocks lagged behind, making them less appealing to investors chasing rapid gains.

However, the landscape has shifted significantly following a market correction and renewed pressures on tech shares, particularly as tariffs introduced by the Trump administration took their toll. As a result, dividend stocks are experiencing a resurgence in interest among investors seeking stability and consistent returns.

The Dividend Aristocrats Index, which tracks companies that have successfully raised their dividends for 25 consecutive years, has shown resilience even as the broader market experienced a downturn. Since the beginning of 2025, this index has seen a modest decline of nearly 2%, in stark contrast to an 8% drop in the overall market. This notable performance suggests that dividends are regaining traction, with many companies initiating or increasing their dividend payouts to attract investors attention.

According to a detailed report by

Isabelle Moreau